Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale Chief Executive Officer sold 125,309 shares at an average $132.34 ($16,583,634)
  2. 4 Open-market sale Chief Executive Officer sold 83,359 shares at an average $182.37 ($15,202,048)
  3. 4 Open-market sale Chief Executive Officer sold 69,216 shares at an average $71.82 ($4,971,360)
  4. 4 Open-market sale Chief Executive Officer sold 70,855 shares at an average $152.13 ($10,778,877)
  5. 4 Open-market sale CMO, Hematology sold 21,000 shares at an average $332.42 ($6,980,771)
  6. 4 Open-market sale Chief Executive Officer sold 67,481 shares at an average $94.83 ($6,399,303)
  7. 4 Open-market sale Chief Executive Officer sold 123,821 shares at an average $117.22 ($14,514,637)
  8. 4 Open-market sale President, COO & GM China sold 10,180 shares at an average $325.53 ($3,313,927)
  9. 4 Open-market sale Director sold 4,848 shares at an average $348.15 ($1,687,852)
  10. 4 Open-market sale Chief Financial Officer sold 308 shares at $349.06 ($107,512)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale CMO, Hematology sold 1,925 shares at an average $354.97 ($683,323)
  13. 4 Open-market sale Global Head of R&D sold 455 shares at $362.48 ($164,930)
  14. 4 Open-market sale CFO & Chief Strategy Officer sold 446 shares at $365.00 ($162,790)
  15. 4 Grant or award Director acquired 7,800 shares (grant or award)
  16. 4 Grant or award Chief Executive Officer acquired 146,250 shares (grant or award)
  17. 4 Grant or award Director acquired 39,000 shares (grant or award)
  18. 4 Open-market sale President, COO & GM China sold 1,156 shares at $330.93 ($382,551)
  19. 4 Open-market sale Global Head of R&D sold 802 shares at $331.15 ($265,583)
  20. 4 Open-market sale CMO, Hematology sold 469 shares at $325.66 ($152,733)

Page 15 of 29 · 580 filings